Aristotle University Of Thessaloniki (AUTH)
Η ΣΥΜΒΟΛΗ ΤΗΣ ΤΑΥΤΟΧΡΟΝΗΣ ΧΗΜΕΙΟ - ΑΚΤΙΝΟΘΕΡΑΠΕΙΑΣ ΜΕ Η ΧΩΡΙΣ ΣΥΜΠΛΗΡΩΜΑΤΙΚΗ ΧΗΜΕΙΟΘΕΡΑΠΕΙΑ ΣΤΗΝ ΕΠΙΒΙΩΣΗ ΑΣΘΕΝΩΝ ΜΕ ΑΔΕΝΟΚΑΡΚΙΝΩΜΑ ΟΡΘΟΥ
Abstract
dc:descriptionAIM: THE AIM OF THIS STUDY WAS TO COMPARE THE IMPACT OF CONCURRENT RADIOTHERAPY (RT) AND CHEMOTHERAPY WITH FLUOROURACIL (FU) VERSUS THIS TREATMENT WITH ADDITIONAL CHEMOTHERAPY WITH LEUKOVORIN (LV) AND FU ON RELAPSE - FREE SURVIVAL (RFS) OF PATIENTS WITH DUKES' B2 OR DUKES' C ADENOCARCINOMA OF THE RECTUM. PATIENTS AND METHODS: 137 PATIENTS WERE RANDOMIZED TO RECEIVE POSTOPERATIVELY EITHER RT (45 GY TO THE PELVIS AND 5.4 GY BOOST TO THE TUMOR AREA) PLUS FU (400 MG/M^2 BOLUS ON THE FIRST 3 AND LAST 3 DAYS OF TREATMENT) (GROUP A) OR THIS TREATMENT AND 4 ADDITIONAL CYCLES OF CHEMOTHERAPY. EACH CYCLE CONSISTED OF LEUKOVORIN (500 MG/M^2 IN 2 - H INFUSION) AND FU (600 MG/M^2 BOLUS MID - INFUSION) WEEKLY FOR SIX WEEKS (GROUP B). RT IN THIS GROUP WAS ADMINISTERED BETWEEN THEFIRST AND THE SECOND CYCLE OF CHEMOTHERAPY. PRIOR TO RANDOMIZATION, ALL PATIENTS WERE STRATIFIED ACCORDING TO CLINICAL STAGE, PRESENCE OF PERIRECTAL FAT, BLOOD OR LYMPHATIC VESSELS INFLILTRATION AND HISTORY OF OBSTRACTION OR PERFORATION AT PRESENTATION. THERE WERE 83 MEN AND 54 WOMEN WITH A MEDIAN AGE OF 57YEARS (RANGE, 33 - 75), 56 PATIENTS (40%) PRESENTED WITH STAGE DUKES' B2 AND 81 (60%) WITH STAGE DUKES' C DISEASE. THIS WAS NO SIGNIFICANT DIFFERENCE IN MAJOR CHARACTERISTICS BETWEEN THE 73 PATIENTS INCLUDED IN GROUP A AND THE 64 PATIENTS INCLUDED IN GROUP B. RESULTS: 84% OF PATIENTS FROM GROUP A AND 81% OF GROUP B COMPLETED THE TREATMENT. GRADE 3 - 4 TOXICITIES WERE OBSERVED ONLY IN GROUP B AND INCLUDED LEUCOPENIA (ABSTRACT TRUNCATED)
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 1997
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Λιάρος, Αχιλλέας
Subjects
dc:subject × 14- ADDITIONAL Χ/Θ
- Adenocarcinoma
- CHEMIO - RADIOTHERAPY
- SIMULTANEOUS Χ/Θ - Α /Θ
- Αδενοκαρκίνωμα
- ΑΚΤΙΝΟΘΕΡΑΠΕΥΤΙΚΗ ΟΓΚΟΛΟΓΙΑ
- ΣΥΜΠΛΗΡΩΜΑΤΙΚΗ ΧΗΜΕΙΟΘΕΡΑΠΕΙΑ
- ΤΑΥΤΟΧΡΟΝΗ ΑΚΤΙΝΟΘΕΡΑΠΕΙΑ
- ΤΑΥΤΟΧΡΟΝΗ ΧΗΜΕΙΟΘΕΡΑΠΕΙΑ
- ΧΗΜΕΙΟ - ΑΚΤΙΝΟΘΕΡΑΠΕΙΑ
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/8789